Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Subscribe

Sci. Signal., 26 March 2013
Vol. 6, Issue 268, p. ec75
[DOI: 10.1126/scisignal.2004169]

EDITORS' CHOICE

Immunology Interfering with Interferons

Kristen L. Mueller

Science, AAAS, Washington, DC 20005, USA

Infections with Mycobacteria, including Mycobacterium leprae or M. tuberculosis, vary substantially in their clinical presentation. For instance, in some cases of M. leprae, the infection is self-healing, with very few lesions. In contrast, some people experience the disseminated form, where skin lesions abound and bacteria are abundant. In patients infected with M. leprae, Teles et al. found that the disseminated disease associates with a type I interferon gene signature, whereas the self-healing form associates with a type II interferon gene signature. In cultured cells, type I interferon and its downstream signaling cascade inhibited the antimicrobial response induced by type II interferons, providing a potential explanation for why robust disease rather than protection is seen in some cases of infection.

R. M. B. Teles, T. G. Graeber, S. R. Krutzik, D. Montoya, M. Schenk, D. J. Lee, E. Komisopoulou, K. Kelly-Scumpia, R. Chun, S. S. Iyer, E. N. Sarno, T. H. Rea, M. Hewison, J. S. Adams, S. J. Popper, D. A. Relman, S. Stenger, B. R. Bloom, G. Cheng, R. L. Modlin, Type I interferon suppresses type II interferon–triggered human anti-mycobacterial responses. Science 339, 1448–1453 (2013). [Abstract] [Full Text]

Citation: K. L. Mueller, Interfering with Interferons. Sci. Signal. 6, ec75 (2013).



To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882